LT - VEGF chimeros, skirtos akių ligų, kurioms būdingas kraujagyslių pralaidumas, gydymui
EN - VEGF receptor chimeras for the treatment of eye disorders characterized by vascular permeability
Legal status
Patent expired
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C12N 15/12 |
(2006.01) |
|
|
C12N 15/62 |
(2006.01) |
|
|
C12N 5/10 |
(2006.01) |
|
|
C07K 14/71 |
(2006.01) |
|
|
A61K 38/17 |
(2006.01) |
|
|
A61P 43/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
1544299 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
05001328.3 |
|
Date of filing the European patent application |
2000-05-23 |
| (97) |
Date of publication of the European application |
2005-06-22 |
| (45) |
Date of publication and mention of the grant of the patent |
2008-12-17
|
| (46) |
Date of publication of the claims translation |
2009-04-27
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
138133 P |
1999-06-08
|
US |
Inventors
| (72) |
Papadopoulos, Nicholas J., US
Wiegand, Stanley J., US
|
Grantee
| (73) |
REGENERON PHARMACEUTICALS, INC.,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
Attorney or representative
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
VEGF chimeros, skirtos akių ligų, kurioms būdingas kraujagyslių pralaidumas, gydymui |
| |
VEGF receptor chimeras for the treatment of eye disorders characterized by vascular permeability |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2019-04-18 |
20 |
347.00
EUR
|
